SANOFI US SERVICES INC. for SANOFI US SERVICES INC
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
Issues related to International Intellectual Property.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACOB ANDREW HARTSFIELD | — |
Pharmacy PHA
General issues related to the 340B Federal Drug Pricing Program.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
Taxation/Internal Revenue Code TAX
All provisions of HR1270 and S709 "Restoring Access to Medication Act of 2015"; issues related to Corporate Tax Reform; and issues related to Department of Treasury regulations on inversions.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| AMY L REDL | — |
Health Issues HCR
Issues related to the Over The Counter (OTC) Monograph reform; general issues related to Zika Outbreaks; issues related to Center for Medicaid and Medicaid Services Innovation Center; Issues related to research and development innovation and education; general issues related to insulin pricing; general issues related to Tropical Disease PRV Program; general issues related to Vaccine Safety; issues related to Access to Adult Vaccines; issues related to H.R. 3299 Strengthening Public Health Emergency Response Act; importation issues related to S.122 Safe and Affordable Drugs from Canada Act of 2015; issues related to pricing and cost value; issues related to the Prescription Drug User Fee Act; and issues related to 21st Century Cures Initiative.
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JACOB ANDREW HARTSFIELD | — |
| AMY L REDL | — |
| FRANCIS JOGUES RIENZO | — |
Medicare/Medicaid MMM
Provisions of S.31 "Medicare Prescription Drug Price Negotiation Act; issues related to Medicare Part B reimbursement; and issues related to Medicare Part D program
Foreign entity interest: Sanofi US Services Inc. is owned by Sanofi SA and to the degree that public policies, either laws or regulations, commercially benefit Sanofi US Services Inc., so too Sanofi SA, as the parent corporation, will benefit.
| Lobbyist | Covered position, as disclosed |
|---|---|
| MARYANNE DOLBEARE DUNLAP | — |
| JACOB ANDREW HARTSFIELD | — |
| AMY L REDL | — |
| FRANCIS JOGUES RIENZO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.